Peter Barton Hutt

Director, MOMENTA PHARMACEUTICALS INC.

Companies

CONCERT PHARMACEUTICALS, INC.Board member Feb 12, 2014 to Mar 6, 2023¹
ModernaBoard member Dec 7, 2018 to Nov 22, 2019²
Decoy Therapeutics Inc.Board member Jan 28, 2015 to Jul 26, 2018³
Selecta Biosciences (United States)Board member Jun 21, 2016 to Jun 19, 2018⁴
XOMA Royalty CorpBoard member May 24, 2006 to May 22, 2017⁵
Seres Therapeutics, Inc.Board member Jun 25, 2015 to Jun 17, 2016⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CONCERT PHARMACEUTICALS, INC.0 shares⁷Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 6, 2023Returned to company 16,400 shares of CONCERT PHARMACEUTICALS, INC.⁷
Mar 6, 2023U 13,088 shares of CONCERT PHARMACEUTICALS, INC.⁷
Oct 14, 2022Sold 3,539 shares at $6.09 of CONCERT PHARMACEUTICALS, INC.⁸
Oct 14, 2022Exercised options 3,539 shares at $2.88 of CONCERT PHARMACEUTICALS, INC.⁸
Jun 9, 2022Granted 16,400 shares of CONCERT PHARMACEUTICALS, INC.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCONCERT PHARMACEUTICALS, INC., Board member
2
SEC EDGARModerna, Board member
3
SEC EDGARDecoy Therapeutics Inc., Board member
4
SEC EDGARSelecta Biosciences (United States), Board member
5
SEC EDGARXOMA Royalty Corp, Board member
6
SEC EDGARSeres Therapeutics, Inc., Board member
7
SEC EDGARCONCERT PHARMACEUTICALS, INC. shares after the filing of Mar 6, 2023
8
SEC EDGARForm 4 filed Oct 18, 2022
9
SEC EDGARForm 4 filed Jun 13, 2022